Tim Pieters

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Genetic Rescue of a Subset of Thyroid Follicular Cells Restores Thyroid Function in Dyshormonogenic Duoxa-/- Mice.

Genetic Rescue of a Subset of Thyroid Follicular Cells Restores Thyroid Function in Dyshormonogenic Duoxa-/- Mice.

Journal: Thyroid : official journal of the American Thyroid Association
Published: November 01, 2025

QKI dysregulation induces extensive splicing changes in T-cell acute lymphoblastic leukemia.

QKI dysregulation induces extensive splicing changes in T-cell acute lymphoblastic leukemia.

Journal: Haematologica
Published: March 25, 2025

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.

Journal: Science advances
Published: November 01, 2024

HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia.

HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia.

Journal: Blood
Published: September 10, 2024

Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia.

Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia.

Journal: Blood
Published: February 12, 2024

Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.

Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.

Journal: Blood advances
Published: October 24, 2023

Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.

Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.

Journal: Haematologica
Published: August 17, 2023

Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.

Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.

Journal: HemaSphere
Published: August 14, 2023

Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids.

Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids.

Journal: Oncogene
Published: May 10, 2023

Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia.

Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia.

Journal: HemaSphere
Published: March 20, 2023

Mutations in the histone methyltransferase Ezh2 drive context-dependent leukemia in Xenopus tropicalis.

Mutations in the histone methyltransferase Ezh2 drive context-dependent leukemia in Xenopus tropicalis.

Journal: Leukemia
Published: January 11, 2023

Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia.

Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia.

Journal: Science advances
Published: December 09, 2022
Showing 1-12 of 45

Last Updated: 09/26/2026